Read more

October 12, 2020
1 min read
Save

NCI scientist receives Samuel D. Gross Prize for surgical research

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Renowned cancer researcher Steven A. Rosenberg, MD, PhD, has been awarded the 2020 Samuel D. Gross Prize for surgical research.

The award — presented once every 5 years by the Philadelphia Academy of Surgery — recognizes the best original research in surgery by an American citizen. Rosenberg will receive the award, along with its $5,000 cash prize, during the Samuel D. Gross Prize Lecture on Nov. 2.

Rosenberg is chief of the surgery branch, senior investigator and head of the tumor immunology section of the NCI’s Center for Cancer Research. One of his primary roles at NCI is to oversee its clinical program aimed at translating scientific research into clinical applications for the immunotherapy of cancer.

Steven Rosenberg
Steven A. Rosenberg

Rosenberg’s previous research pioneered the use of adoptive cell therapies that have achieved complete remissions in patients with advanced melanoma, sarcomas and lymphomas. His current research has focused on developing cellular immunotherapies through the identification of new antigens as targets for human infiltrating lymphocytes that can recognize and eliminate cancer cells.

“I am honored and humbled to receive this award, named for one of our great American surgeons,” Rosenberg told Healio.

The Gross Prize — first awarded in 1895 — was established by Samuel D. Gross, founder of the Philadelphia Academy of Surgery. The award is the world’s oldest surgical research prize, according to the academy.